Tiger Brokers

BUZZ-WuXi Biologics climbs to 4-month high on robust earnings estimates

Reuters
Feb 11
BUZZ-WuXi Biologics climbs to 4-month high on robust earnings estimates

** Shares of WuXi Biologics (Cayman) Inc 2269.HK climb 4.1% to HK$41.68, their highest level since October 9

** Stock on track for a fifth straight session of gain

** Co expects its 2025 profit attributable to equity shareholders to rise 46.3% y/y to 4.91 bln yuan ($710.21 mln)

** Revenue seen up 16.7% at 21.79 bln yuan and the gross profit margin rate is expected to expand by 5 percentage points to 46%

** Co says the increase is due to enlarged spectrum of services offered to the biologics industry, growth of research services revenue, cost savings and efficiency improvements, among others

** YTD, stock up 29.9%, the Hang Seng Biotech Index .HSBIO up 13.3%

($1 = 6.9106 Chinese yuan)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10